FDA Approved: KADCYLA — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved KADCYLA (ado-trastuzumab emtansine) from Genentech as an original application for the treatment of HER2-positive metastatic breast cancer in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)

Snippet

ORIG AP for KADCYLA (ADO-TRASTUZUMAB EMTANSINE)